Literature DB >> 18374270

Propagation of protein glycation damage involves modification of tryptophan residues via reactive oxygen species: inhibition by pyridoxamine.

Sergei V Chetyrkin1, Missy E Mathis, Amy-Joan L Ham, David L Hachey, Billy G Hudson, Paul A Voziyan.   

Abstract

Nonenzymatic modification of proteins is one of the key pathogenic factors in diabetic complications. Uncovering the mechanisms of protein damage caused by glucose is fundamental to understanding this pathogenesis and in the development of new therapies. We investigated whether the mechanism involving reactive oxygen species can propagate protein damage in glycation reactions beyond the classical modifications of lysine and arginine residues. We have demonstrated that glucose can cause specific oxidative modification of tryptophan residues in lysozyme and inhibit lysozyme activity. Furthermore, modification of tryptophan residues was also induced by purified albumin-Amadori, a ribose-derived model glycation intermediate. The AGE inhibitor pyridoxamine (PM) prevented the tryptophan modification, whereas another AGE inhibitor and strong carbonyl scavenger, aminoguanidine, was ineffective. PM specifically inhibited generation of hydroxyl radical from albumin-Amadori and protected tryptophan from oxidation by hydroxyl radical species. We conclude that oxidative degradation of either glucose or the protein-Amadori intermediate causes oxidative modification of protein tryptophan residues via hydroxyl radical and can affect protein function under physiologically relevant conditions. This oxidative stress-induced structural and functional protein damage can be ameliorated by PM via sequestration of catalytic metal ions and scavenging of hydroxyl radical, a mechanism that may contribute to the reported therapeutic effects of PM in the complications of diabetes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18374270     DOI: 10.1016/j.freeradbiomed.2007.09.016

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  15 in total

1.  Inhibiting Effect of Zinc Oxide Nanoparticles on Advanced Glycation Products and Oxidative Modifications: a Potential Tool to Counteract Oxidative Stress in Neurodegenerative Diseases.

Authors:  Jalaluddin M Ashraf; Mohammad Azam Ansari; Sana Fatma; Saleh M S Abdullah; Johar Iqbal; Aymen Madkhali; Al Hassan Hamali; Saheem Ahmad; Ahmed Jerah; Valentina Echeverria; George E Barreto; Ghulam Md Ashraf
Journal:  Mol Neurobiol       Date:  2018-02-08       Impact factor: 5.590

Review 2.  Photo-Degradation of Therapeutic Proteins: Mechanistic Aspects.

Authors:  Christian Schöneich
Journal:  Pharm Res       Date:  2020-02-03       Impact factor: 4.200

3.  Pyridorin in type 2 diabetic nephropathy.

Authors:  Edmund J Lewis; Tom Greene; Samuel Spitalewiz; Samuel Blumenthal; Tomas Berl; Lawrence G Hunsicker; Marc A Pohl; Richard D Rohde; Itamar Raz; Yair Yerushalmy; Yoram Yagil; Tommy Herskovits; Robert C Atkins; Anne T Reutens; David K Packham; Julia B Lewis
Journal:  J Am Soc Nephrol       Date:  2011-10-27       Impact factor: 10.121

4.  Diabetic nephropathy induces alterations in the glomerular and tubule lipid profiles.

Authors:  Kerri J Grove; Paul A Voziyan; Jeffrey M Spraggins; Suwan Wang; Paisit Paueksakon; Raymond C Harris; Billy G Hudson; Richard M Caprioli
Journal:  J Lipid Res       Date:  2014-05-26       Impact factor: 5.922

5.  Glucose autoxidation induces functional damage to proteins via modification of critical arginine residues.

Authors:  Sergei Chetyrkin; Missy Mathis; Vadim Pedchenko; Otto A Sanchez; W Hayes McDonald; David L Hachey; Hartman Madu; Donald Stec; Billy Hudson; Paul Voziyan
Journal:  Biochemistry       Date:  2011-06-20       Impact factor: 3.162

6.  Pyridoxamine protects protein backbone from oxidative fragmentation.

Authors:  Sergei Chetyrkin; Missy Mathis; W Hayes McDonald; Xavier Shackelford; Billy Hudson; Paul Voziyan
Journal:  Biochem Biophys Res Commun       Date:  2011-07-13       Impact factor: 3.575

7.  Comparative study of different glycating agents on human plasma and vascular cells.

Authors:  Rashmi S Tupe; Nilima Bangar; Arundhati Diwan; Dhanashri Changale; Shivani Choudhary; Shubhangi Chaware
Journal:  Mol Biol Rep       Date:  2019-11-12       Impact factor: 2.316

8.  Ribosylation of bovine serum albumin induces ROS accumulation and cell death in cancer line (MCF-7).

Authors:  Mohd Shahnawaz Khan; Sourabh Dwivedi; Medha Priyadarshini; Shams Tabrez; Maqsood Ahmed Siddiqui; Haseeb Jagirdar; Abdulrahman M Al-Senaidy; Abdulaziz A Al-Khedhairy; Javed Musarrat
Journal:  Eur Biophys J       Date:  2013-11-12       Impact factor: 1.733

Review 9.  Implications of treatment that target protective mechanisms against diabetic nephropathy.

Authors:  Akira Mima; Weier Qi; George L King
Journal:  Semin Nephrol       Date:  2012-09       Impact factor: 5.299

10.  Rapid glycation with D-ribose induces globular amyloid-like aggregations of BSA with high cytotoxicity to SH-SY5Y cells.

Authors:  Yan Wei; Lan Chen; Ji Chen; Lin Ge; Rong Qiao He
Journal:  BMC Cell Biol       Date:  2009-02-13       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.